On the basis of the monitoring data obtained for the other five substances or groups of substances monitored since 2022, namely fipronil, clindamycin, ofloxacin, metformin and its metabolite guanylurea, and a group of three sunscreen agents (butyl methoxydibenzoylmethane, also known as avobenzone; octocrylene; and benzophenone-3, also known as oxybenzone), the Commission concluded that insufficient high-quality monitoring data had been obtained to assess the risk posed by them, and that, therefore, those substances or groups of substances should remain on the watch list.
Recital 8, Decision_act (EU) 2025/439
In forcesince 28 Feb 2025